Cryosite Ltd
ASX:CTE

Watchlist Manager
Cryosite Ltd Logo
Cryosite Ltd
ASX:CTE
Watchlist
Price: 1 AUD Market Closed
Market Cap: 48.8m AUD

Cryosite Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cryosite Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cryosite Ltd
ASX:CTE
Cash from Operating Activities
AU$2.1m
CAGR 3-Years
-6%
CAGR 5-Years
9%
CAGR 10-Years
4%
Anteotech Ltd
ASX:ADO
Cash from Operating Activities
-AU$5.8m
CAGR 3-Years
12%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Proteomics International Laboratories Ltd
ASX:PIQ
Cash from Operating Activities
-AU$6.6m
CAGR 3-Years
-23%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Cash from Operating Activities
AU$10.8m
CAGR 3-Years
58%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Genetic Signatures Ltd
ASX:GSS
Cash from Operating Activities
-AU$12.3m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Cash from Operating Activities
AU$4.4m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Cryosite Ltd
Glance View

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

CTE Intrinsic Value
0.78 AUD
Overvaluation 22%
Intrinsic Value
Price

See Also

What is Cryosite Ltd's Cash from Operating Activities?
Cash from Operating Activities
2.1m AUD

Based on the financial report for Jun 30, 2025, Cryosite Ltd's Cash from Operating Activities amounts to 2.1m AUD.

What is Cryosite Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
4%

Over the last year, the Cash from Operating Activities growth was -25%. The average annual Cash from Operating Activities growth rates for Cryosite Ltd have been -6% over the past three years , 9% over the past five years , and 4% over the past ten years .

Back to Top